Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
<iframe src="https://statesidedaily.com/embed/cluster/4e8007048ded49093a194bd1c34e924e68e4f69c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?"></iframe>
